Summary by Moomoo AI
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares of the company on 06/11/2024, as per the latest filing. The shares, valued at approximately $96,762.82, were originally acquired as founders shares on 09/01/2016 as part of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 85,896 Class A shares were sold by Borgeson, generating gross proceeds of $803,931.52. The upcoming sale reflects ongoing trading activity by the director, with the specific intent and plan for this sale having been adopted on 08/18/2023.